Alkyl Amines Chemicals Q1FY26 net profit surges 91% to ₹94.63 crore
Alkyl Amines Chemicals reported a 91% YoY rise in Q1FY26 net profit to ₹94.63 crore, driven by 30% revenue growth to ₹528.01 crore. The Board also approved key director re-designations effective October 1, 2026.

*this image is generated using AI for illustrative purposes only.
Alkyl Amines Chemicals reported a robust set of financial results for the quarter ended June 30, 2026, with net profit surging 91% year-on-year to ₹94.63 crore. The significant earnings growth, supported by a 30% increase in revenue from operations to ₹528.01 crore, reflects strong operational efficiency and margin expansion in the specialty chemicals segment. Alongside the financial results, the Board of Directors approved strategic re-designations of key leadership roles to ensure continuity and succession planning.
Strong Revenue and Profitability Growth
Revenue from operations for Q1FY26 stood at ₹528.01 crore, up from ₹405.53 crore in the corresponding quarter of FY25. This top-line growth was accompanied by substantial margin improvement. Profit before tax rose sharply to ₹124.67 crore from ₹66.34 crore YoY. Net profit after tax was ₹94.63 crore vs ₹49.44 crore YoY.
The following table summarises the key financial metrics for Q1FY26 on a year-on-year basis:
| Metric | Q1FY26 (₹ Cr) | Q1FY25 (₹ Cr) | Change |
|---|---|---|---|
| Revenue from Operations | 528.01 | 405.53 | +30.2% |
| Total Revenue | 537.31 | 413.49 | +29.9% |
| Profit Before Tax | 124.67 | 66.34 | +87.9% |
| Net Profit After Tax | 94.63 | 49.44 | +91.4% |
| EPS (Basic) | ₹18.50 | ₹9.67 | +91.3% |
Margin Expansion and Operational Efficiency
The company demonstrated improved cost management, with total expenses rising to ₹412.64 crore from ₹347.15 crore year-on-year, a growth rate lower than revenue expansion. Cost of materials consumed increased to ₹316.09 crore from ₹218.31 crore, while employee benefit costs rose to ₹36.31 crore from ₹27.30 crore. The profit before tax margin expanded significantly, driving the near-doubling of net profit. Earnings per share (basic) jumped to ₹18.50 from ₹9.67 in the previous year's quarter.
Board Approves Director Re-designations
In a separate resolution, the Board approved the re-designation of several directors effective October 1, 2026, subject to shareholder approval via postal ballot:
- Yogesh M. Kothari: Re-designated as Executive Chairman (Whole-time Director) until March 31, 2030.
- Kirat M. Patel: Re-designated as Joint Managing Director until December 31, 2029.
- Suneet Y. Kothari: Re-designated as Joint Managing Director until December 31, 2029.
- Rakesh Goyal: Re-designated and appointed as Executive Director – Operations for five years from April 1, 2027.
The Board also approved payment of commission to Non-Executive Directors at a rate not exceeding 1% of net profits for five years starting April 1, 2027. The trading window for designated persons will open on August 7, 2026.
Historical Stock Returns for Alkyl Amines Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.29% | +5.46% | +5.15% | +18.67% | -14.97% | -55.09% |
Will the current margin expansion driven by operational efficiency be sustainable in the face of potential raw material price volatility in the specialty chemicals sector?
How might the re-designation of Yogesh M. Kothari as Executive Chairman and the appointment of Rakesh Goyal impact the company's strategic focus on operational execution and market expansion?
Given the 30% revenue growth, what specific new product lines or geographic markets are driving this top-line expansion for Alkyl Amines Chemicals?


































